Unrelated Donor Transplantation for Acute Myelogenous Leukemia in First Remission

We retrospectively analyzed the outcomes of all acute myelogenous leukemia (AML) patients in first remission (n = 44; median age = 48 years; high-risk cytogenetics = 59%) who received unrelated donor hematopoietic cell transplantation (HCT) with myeloablative conditioning regimen of i.v. busulfan, f...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Bashir, Qaiser, Andersson, Borje S., Fernandez-Vina, Marcelo, de Padua Silva, Leandro, Giralt, Sergio, Chiattone, Alexandre, Wei, Wei, Sharma, Manish, Anderlini, Paolo, Shpall, Elizabeth J., Popat, Uday, Rodrigues, Morgani, Champlin, Richard E., de Lima, Marcos
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4080632/
https://ncbi.nlm.nih.gov/pubmed/21087679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2010.11.012
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller